Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
August 19, 2015
Utility of event-related potentials in predicting antidepressant treatment response: An iSPOT-D report
Rik van Dinteren, Martijn Arns, Leon Kenemans, et al.
Psychoneuroendocrinology
|
April 8, 2014
A four week randomised control trial of adjunctive medroxyprogesterone and tamoxifen in women with mania
Jayashri Kulkarni, Michael Berk, Wei Wang, et al.
Plos One
|
April 12, 2019
Rhabdomyosarcoma and Wilms tumors contain a subpopulation of noggin producing, myogenic cells immunoreactive for lens beaded filament proteins
Jacquelyn Gerhart, Kathryn Behling, Michele Paessler, et al.
Journal of X-Ray Science and Technology
|
February 19, 2016
Cardiac CT: A system architecture study
Paul FitzGerald, James Bennett, Jeffrey Carr, et al.
Pediatric Blood & Cancer
|
September 11, 2010
Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma
Alekist Quach, Lingyun Ji, Vikash Mishra, et al.
Nature Communications
|
March 11, 2020
Author Correction: Noninvasive sub-organ ultrasound stimulation for targeted neuromodulation
Victoria Cotero, Ying Fan, Tea Tsaava, et al.
Nature Communications
|
March 14, 2019
Noninvasive sub-organ ultrasound stimulation for targeted neuromodulation
Victoria Cotero, Ying Fan, Tea Tsaava, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
October 14, 2024
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial - CORRIGENDUM
Colleen Loo, Nick Glozier, David Barton, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
December 18, 2023
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial
Colleen Loo, Nick Glozier, David Barton, et al.
Brain Stimulation
|
May 16, 2020
Guidelines for TMS/tES clinical services and research through the COVID-19 pandemic
Marom Bikson, Colleen A Hanlon, Adam J Woods, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
August 19, 2015
Utility of event-related potentials in predicting antidepressant treatment response: An iSPOT-D report
Rik van Dinteren, Martijn Arns, Leon Kenemans, et al.
Psychoneuroendocrinology
|
April 8, 2014
A four week randomised control trial of adjunctive medroxyprogesterone and tamoxifen in women with mania
Jayashri Kulkarni, Michael Berk, Wei Wang, et al.
Plos One
|
April 12, 2019
Rhabdomyosarcoma and Wilms tumors contain a subpopulation of noggin producing, myogenic cells immunoreactive for lens beaded filament proteins
Jacquelyn Gerhart, Kathryn Behling, Michele Paessler, et al.
Journal of X-Ray Science and Technology
|
February 19, 2016
Cardiac CT: A system architecture study
Paul FitzGerald, James Bennett, Jeffrey Carr, et al.
Pediatric Blood & Cancer
|
September 11, 2010
Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma
Alekist Quach, Lingyun Ji, Vikash Mishra, et al.
Nature Communications
|
March 11, 2020
Author Correction: Noninvasive sub-organ ultrasound stimulation for targeted neuromodulation
Victoria Cotero, Ying Fan, Tea Tsaava, et al.
Nature Communications
|
March 14, 2019
Noninvasive sub-organ ultrasound stimulation for targeted neuromodulation
Victoria Cotero, Ying Fan, Tea Tsaava, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
October 14, 2024
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial - CORRIGENDUM
Colleen Loo, Nick Glozier, David Barton, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
December 18, 2023
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial
Colleen Loo, Nick Glozier, David Barton, et al.
Brain Stimulation
|
May 16, 2020
Guidelines for TMS/tES clinical services and research through the COVID-19 pandemic
Marom Bikson, Colleen A Hanlon, Adam J Woods, et al.
Page
of 9